[Evolution of the management of pediatric and adult medulloblastoma]

Cancer Radiother. 2015 Aug;19(5):347-57; quiz 358-9, 362. doi: 10.1016/j.canrad.2015.03.010. Epub 2015 Jul 2.
[Article in French]

Abstract

Medulloblastoma are cerebellar tumours belonging to the group of primitive neuroectodermal tumours (PNET) and are the most common malignant brain tumours of childhood. These tumours are rare and heterogeneous, requiring some multicentric prospective studies and multidisciplinary care. The classical therapeutic approaches are based on clinical, radiological and surgical data. They involve surgery, radiation therapy and chemotherapy. Some histological features were added to characterize risk. More recently, molecular knowledge has allowed to devise risk-adapted strategies and helped to define groups with good outcome and reduce long-term sequelae, improve the prognostic of high-risk medulloblastoma and develop new therapeutic tools.

Keywords: Adult; Adulte; Child; Enfant; Management; Medulloblastoma; Médulloblastomes; Prise en charge.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Adult
  • Cerebellar Neoplasms / classification
  • Cerebellar Neoplasms / diagnosis
  • Cerebellar Neoplasms / metabolism
  • Cerebellar Neoplasms / therapy*
  • Chemotherapy, Adjuvant
  • Child
  • Developmental Disabilities / etiology
  • Genetic Predisposition to Disease
  • Hedgehog Proteins / metabolism
  • Humans
  • Magnetic Resonance Imaging
  • Medulloblastoma / classification
  • Medulloblastoma / diagnosis
  • Medulloblastoma / metabolism
  • Medulloblastoma / therapy*
  • Mutism / etiology
  • Neoplasm Recurrence, Local
  • Postoperative Care
  • Prognosis
  • Radiotherapy, Adjuvant
  • Randomized Controlled Trials as Topic
  • Risk Assessment
  • Wnt Proteins / metabolism

Substances

  • Hedgehog Proteins
  • Wnt Proteins